BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23640037)

  • 1. Glucocorticoid induction of occludin expression and endothelial barrier requires transcription factor p54 NONO.
    Keil JM; Liu X; Antonetti DA
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4007-15. PubMed ID: 23640037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoids induce transactivation of tight junction genes occludin and claudin-5 in retinal endothelial cells via a novel cis-element.
    Felinski EA; Cox AE; Phillips BE; Antonetti DA
    Exp Eye Res; 2008 Jun; 86(6):867-78. PubMed ID: 18501346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mechanism for glucocorticoid-induced tightening of endothelial barriers.
    Duh EJ
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4016. PubMed ID: 23759428
    [No Abstract]   [Full Text] [Related]  

  • 4. p54nrb/NONO regulates cyclic AMP-dependent glucocorticoid production by modulating phosphodiesterase mRNA splicing and degradation.
    Lu JY; Sewer MB
    Mol Cell Biol; 2015 Apr; 35(7):1223-37. PubMed ID: 25605330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoids exert differential effects on the endothelium in an in vitro model of the blood-retinal barrier.
    van der Wijk AE; Canning P; van Heijningen RP; Vogels IMC; van Noorden CJF; Klaassen I; Schlingemann RO
    Acta Ophthalmol; 2019 Mar; 97(2):214-224. PubMed ID: 30168271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of MAPKs in endostatin-mediated regulation of blood-retinal barrier function.
    Campbell M; Collery R; McEvoy A; Gardiner TA; Stitt AW; Brankin B
    Curr Eye Res; 2006 Dec; 31(12):1033-45. PubMed ID: 17169842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF but not PlGF disturbs the barrier of retinal endothelial cells.
    Deissler HL; Deissler H; Lang GK; Lang GE
    Exp Eye Res; 2013 Oct; 115():162-71. PubMed ID: 23891860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial characterization of the human retinal endothelial cell tight and adherens junction complexes.
    Russ PK; Davidson MK; Hoffman LH; Haselton FR
    Invest Ophthalmol Vis Sci; 1998 Nov; 39(12):2479-85. PubMed ID: 9804158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic identification of PSF and p54(nrb) as TopBP1-interacting proteins.
    Kuhnert A; Schmidt U; Monajembashi S; Franke C; Schlott B; Grosse F; Greulich KO; Saluz HP; Hänel F
    J Cell Biochem; 2012 May; 113(5):1744-53. PubMed ID: 22213094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transcription-splicing protein NonO/p54nrb and three NonO-interacting proteins bind to distal enhancer region and augment rhodopsin expression.
    Yadav SP; Hao H; Yang HJ; Kautzmann MA; Brooks M; Nellissery J; Klocke B; Seifert M; Swaroop A
    Hum Mol Genet; 2014 Apr; 23(8):2132-44. PubMed ID: 24301678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel co-culture model of the blood-retinal barrier based on primary retinal endothelial cells, pericytes and astrocytes.
    Wisniewska-Kruk J; Hoeben KA; Vogels IM; Gaillard PJ; Van Noorden CJ; Schlingemann RO; Klaassen I
    Exp Eye Res; 2012 Mar; 96(1):181-90. PubMed ID: 22200486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group.
    Antonetti DA; Barber AJ; Khin S; Lieth E; Tarbell JM; Gardner TW
    Diabetes; 1998 Dec; 47(12):1953-9. PubMed ID: 9836530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The multifunctional protein p54nrb/PSF recruits the exonuclease XRN2 to facilitate pre-mRNA 3' processing and transcription termination.
    Kaneko S; Rozenblatt-Rosen O; Meyerson M; Manley JL
    Genes Dev; 2007 Jul; 21(14):1779-89. PubMed ID: 17639083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p54nrb is a new regulator of progression of malignant melanoma.
    Schiffner S; Zimara N; Schmid R; Bosserhoff AK
    Carcinogenesis; 2011 Aug; 32(8):1176-82. PubMed ID: 21642354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of Matrin 3 and SFPQ/NONO in the DNA damage response.
    Salton M; Lerenthal Y; Wang SY; Chen DJ; Shiloh Y
    Cell Cycle; 2010 Apr; 9(8):1568-76. PubMed ID: 20421735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PSF.p54nrb complex is a novel Mnk substrate that binds the mRNA for tumor necrosis factor alpha.
    Buxadé M; Morrice N; Krebs DL; Proud CG
    J Biol Chem; 2008 Jan; 283(1):57-65. PubMed ID: 17965020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Norrin restores blood-retinal barrier properties after vascular endothelial growth factor-induced permeability.
    Díaz-Coránguez M; Lin CM; Liebner S; Antonetti DA
    J Biol Chem; 2020 Apr; 295(14):4647-4660. PubMed ID: 32086377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p54(nrb)/NONO regulates lipid metabolism and breast cancer growth through SREBP-1A.
    Zhu Z; Zhao X; Zhao L; Yang H; Liu L; Li J; Wu J; Yang F; Huang G; Liu J
    Oncogene; 2016 Mar; 35(11):1399-410. PubMed ID: 26148231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endostatin modulates VEGF-mediated barrier dysfunction in the retinal microvascular endothelium.
    Brankin B; Campbell M; Canning P; Gardiner TA; Stitt AW
    Exp Eye Res; 2005 Jul; 81(1):22-31. PubMed ID: 15978251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase cβ phosphorylates occludin regulating tight junction trafficking in vascular endothelial growth factor-induced permeability in vivo.
    Murakami T; Frey T; Lin C; Antonetti DA
    Diabetes; 2012 Jun; 61(6):1573-83. PubMed ID: 22438576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.